Corporate Analysis
By Ian Tang, Gabe Armstrong-Scott, and JB Ferguson

Corporate Analysis
By Ian Tang, Gabe Armstrong-Scott, and JB Ferguson
We want to hear from you. Let us know your question and a research analyst will get back to you promptly. We love to discuss our research.
Connect
The rapid advancement of AI and its near ubiquity will have underappreciated consequences for consumer-facing regulated businesses—developments the industry may not be ready for. Already, ChatGPT, Claude, and other large language models (LLMs) reduce not...
Capstone believes investors should focus on four key regulatory dynamics that separate signal from noise in the RCM landscape. Amid regulatory flux that includes Medicaid work requirements, ACA subsidy expiration, and AI restrictions, RCM vendors face a dramatic...
Capstone's PE Scrutiny Legislation Tracker Capstone believes California’s recent passage of a corporate practice of medicine (CPOM) law and legislation expanding healthcare transaction notice laws signal that state-level appetite for more onerous restrictions around...